The Senate committee charged with reviewing the nomination of Dr. Stephen Hahn as the next FDA Commissioner has approved his appointment by an 18-to-5 vote, sending the nomination to a
Dr. Stephen Hahn, a chief medical executive at the University of Texas MD Anderson Cancer Center in Houston, likely will be the next Food and Drug Administration (FDA), Commissioner.
President
